These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 38298622)

  • 1. Therapeutic strategy of biological macromolecules based natural bioactive compounds of diabetes mellitus and future perspectives: A systematic review.
    Shahzad N; Alzahrani AR; Aziz Ibrahim IA; Shahid I; Alanazi IM; Falemban AH; Imam MT; Mohsin N; Azlina MFN; Arulselvan P
    Heliyon; 2024 Jan; 10(2):e24207. PubMed ID: 38298622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Review on the Delivery of Plant-Based Antidiabetic Agents Using Nanocarriers: Current Status and Their Role in Combatting Hyperglycaemia.
    Zolkepli H; Widodo RT; Mahmood S; Salim N; Awang K; Ahmad N; Othman R
    Polymers (Basel); 2022 Jul; 14(15):. PubMed ID: 35893954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanocarriers and Diabetes: New Vistas and the Way Ahead.
    Dixit PV; Mishra DK; Sharma S; Gautam RK
    Curr Pharm Biotechnol; 2023; 24(11):1420-1429. PubMed ID: 36578251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forty-One Plant Extracts Screened for Dual Antidiabetic and Antioxidant Functions: Evaluating the Types of Correlation between -Amylase Inhibition and Free Radical Scavenging.
    Bashkin A; Ghanim M; Abu-Farich B; Rayan M; Miari R; Srouji S; Rayan A; Falah M
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33435419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herbal Nanoformulations for Diabetes: Mechanisms, Formulations, and Clinical Impact.
    Sunita M; Kaushik R; Verma KK; Parveen R
    Curr Diabetes Rev; 2024 Mar; ():. PubMed ID: 38500279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioactive Compounds in Anti-Diabetic Plants: From Herbal Medicine to Modern Drug Discovery.
    Tran N; Pham B; Le L
    Biology (Basel); 2020 Aug; 9(9):. PubMed ID: 32872226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent developments in nanoparticles for the treatment of diabetes.
    Sharma DK; Pattnaik G; Behera A
    J Drug Target; 2023 Dec; 31(9):908-919. PubMed ID: 37725445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herbal Nanoformulations for Asthma Treatment.
    Yang J; Song B; Wu J
    Curr Pharm Des; 2022; 28(1):46-57. PubMed ID: 34587880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demystifying the Potential of Embelin-Loaded Nanoformulations: a Comprehensive Review.
    Noor L; Hafeez A; Rahman MA; Vishwakarma KK; Kapoor A; Ara N; Aqeel R
    AAPS PharmSciTech; 2024 Oct; 25(8):249. PubMed ID: 39433611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the potential of nanocarriers in antipsoriatic therapeutics.
    Shaif M; Kushwaha P; Usmani S; Pandey S
    J Dermatolog Treat; 2022 Nov; 33(7):2919-2930. PubMed ID: 35729857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoformulation of Plant-Based Natural Products for Type 2 Diabetes Mellitus: From Formulation Design to Therapeutic Applications.
    Wickramasinghe ASD; Kalansuriya P; Attanayake AP
    Curr Ther Res Clin Exp; 2022; 96():100672. PubMed ID: 35586563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploration of Lipid-Based Nanocarriers as Drug Delivery Systems in Diabetic Foot Ulcer.
    Kandregula B; Narisepalli S; Chitkara D; Mittal A
    Mol Pharm; 2022 Jul; 19(7):1977-1998. PubMed ID: 35481377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of blood glucose by plant extracts and their use in the treatment of diabetes mellitus; discrepancies in effectiveness between animal and human studies.
    Furman BL; Candasamy M; Bhattamisra SK; Veettil SK
    J Ethnopharmacol; 2020 Jan; 247():112264. PubMed ID: 31600561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding glycaemic control and current approaches for screening antidiabetic natural products from evidence-based medicinal plants.
    Lankatillake C; Huynh T; Dias DA
    Plant Methods; 2019; 15():105. PubMed ID: 31516543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the plant-derived bioactive substances as antidiabetic agent: An extensive review.
    Rahman MM; Dhar PS; Sumaia ; Anika F; Ahmed L; Islam MR; Sultana NA; Cavalu S; Pop O; Rauf A
    Biomed Pharmacother; 2022 Aug; 152():113217. PubMed ID: 35679719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid lipid nanoparticles for hydrophilic drugs.
    Mirchandani Y; Patravale VB; S B
    J Control Release; 2021 Jul; 335():457-464. PubMed ID: 34048841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanocarrier Based Delivery of Berberine: A Critical Review on Pharmaceutical and Preclinical Characteristics of the Bioactive.
    Khan MJ; Hafeez A; Siddiqui MA
    Curr Pharm Biotechnol; 2023; 24(11):1449-1464. PubMed ID: 36635907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehending the potential of metallic, lipid, and polymer-based nanocarriers for treatment and management of depression.
    Patel RB; Rao HR; Thakkar DV; Patel MR
    Neurochem Int; 2022 Feb; 153():105259. PubMed ID: 34942308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticulate-based drug delivery systems for small molecule anti-diabetic drugs: An emerging paradigm for effective therapy.
    Uppal S; Italiya KS; Chitkara D; Mittal A
    Acta Biomater; 2018 Nov; 81():20-42. PubMed ID: 30268916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herbal nanomedicines: Recent advancements, challenges, opportunities and regulatory overview.
    Teja PK; Mithiya J; Kate AS; Bairwa K; Chauthe SK
    Phytomedicine; 2022 Feb; 96():153890. PubMed ID: 35026510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.